TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive DCT Board Committee Recommends Limited Start On In Vitro Screening Program January 18, 1985
TCL Archive CMS Launches National Coverage Analysis, Citing FDA’s Black Box Warning on ESAs. March 16, 2007
TCL Archive Regulatory Agencies: FDA To Increase Fees For Mammography Facility Inspections January 30, 1998
